These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15667585)

  • 1. Tensegrity and type 1 dermal dendrocytes in acromegaly.
    Quatresooz P; Hermanns-Lê T; Ciccarelli A; Beckers A; Piérard GE
    Eur J Clin Invest; 2005 Feb; 35(2):133-9. PubMed ID: 15667585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel interactions between dermal dendrocytes and mast cells in human skin. Implications for hemostasis and matrix repair.
    Sueki H; Whitaker D; Buchsbaum M; Murphy GF
    Lab Invest; 1993 Aug; 69(2):160-72. PubMed ID: 8102416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis.
    Lago E; Carneiro S; Cuzzi T; Magalhães G; Cássia F; Pessanha F; Ramos-e-Silva M
    J Cutan Pathol; 2007 Jan; 34(1):15-21. PubMed ID: 17214849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status.
    Espinosa-de-Los-Monteros AL; Sosa E; Cheng S; Ochoa R; Sandoval C; Guinto G; Mendoza V; Hernández I; Molina M; Mercado M
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):245-9. PubMed ID: 16487431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
    Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
    Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
    van der Hoek J; van der Lelij AJ; Feelders RA; de Herder WW; Uitterlinden P; Poon KW; Boerlin V; Lewis I; Krahnke T; Hofland LJ; Lamberts SW
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis.
    Yasuoka H; Jukic DM; Zhou Z; Choi AM; Feghali-Bostwick CA
    Arthritis Rheum; 2006 Sep; 54(9):3001-10. PubMed ID: 16947625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
    Jallad RS; Musolino NR; Salgado LR; Bronstein MD
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
    Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis is reduced in the colonic mucosa of patients with acromegaly.
    Bogazzi F; Russo D; Locci MT; Chifenti B; Ultimieri F; Raggi F; Cosci C; Sardella C; Costa A; Gasperi M; Bartalena L; Martino E
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):683-8. PubMed ID: 16343104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of granulocyte macrophage-colony stimulating factor on extracellular matrix deposition by dermal fibroblasts from patients with scleroderma.
    Postiglione L; Ladogana P; Montagnani S; di Spigna G; Castaldo C; Turano M; Bruno EM; Di Meglio F; Riccio A; Rossi G
    J Rheumatol; 2005 Apr; 32(4):656-64. PubMed ID: 15801021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The choice of therapy in acromegaly: results of treatment at a tertiary care hospital.
    Isidro ML; Castro JA; Penín M; Armenta J; Cordido F
    Neuro Endocrinol Lett; 2008 Dec; 29(6):1038-44. PubMed ID: 19112390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly.
    Gutt B; Wowra B; Alexandrov R; Uhl E; Schaaf L; Stalla GK; Schopohl J
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):219-24. PubMed ID: 15891958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly.
    Jaskula M; Wasko R; Komarowska H; Dziubandowska A; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):245-55. PubMed ID: 19675514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
    Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical aspects of the fibrogenic pathway in nephrogenic systemic fibrosis.
    Quatresooz P; Paquet P; Hermanns-Lê T; Piérard GE
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):448-52. PubMed ID: 20485155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatopathological aspects of restrictive dermopathy.
    Piérard-Franchimont C; Piérard GE; Hermanns-Lê T; Estrada JA; Verloes A; Mulliez N
    J Pathol; 1992 Jun; 167(2):223-8. PubMed ID: 1353115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.
    Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.